American Association for the Study of Liver Diseases (AASLD)
David J. Reich, MD, FACS, currently serves as the Director of the Liver Transplant Program and Chief of the Innovative Technology & Therapeutics Program at Cleveland Clinic since August 2022. Reich holds professorships in Surgery and Biomedical Engineering at Drexel University since 2008 and 2022, respectively. Over the years, Reich has held various leadership roles within the United Network for Organ Sharing (UNOS), including Treasurer and Board of Directors member, and has made significant contributions to the American Society of Transplant Surgeons, chairing multiple committees focused on strategic planning and standards. Additionally, Reich has been involved with the American Association for the Study of Liver Diseases as a Fellow and held leadership positions from 2003 onwards. Reich is also a board member of the Gift of Life Donor Program and serves as Medical Affairs Lead at Bridge to Life Ltd. Education includes a Doctor of Medicine from McGill University and a Bachelor of Arts from Columbia College, Columbia University.
This person is not in any teams
This person is not in any offices
American Association for the Study of Liver Diseases (AASLD)
The American Association for the Study of Liver Diseases (AASLD) is the nation’s premier organization of physicians, scientists, researchers, medical students, and healthcare professionals to study, prevent, and cure liver diseases. AASLD was founded in 1950 by a group of leading liver specialists to advance the field of hepatology. The mission of AASLD is to advance and disseminate the science and practice of hepatology and to promote improved liver health and quality patient care. AASLD has more than 7,000 + members who work in hepatology and related areas. AASLD advances the study and treatment of liver diseases in these diverse ways: · The Liver Meeting, AASLD’s annual meeting that features interactive sessions on the latest breakthroughs, advancements, and research in liver health, education workshops, and exhibits featuring state-of-the-art technologies, pharmaceutical developments, and medical devices. · Practice guidelines developed by a multidisciplinary panel of experts to share recommended approaches to the diagnosis, therapeutic, and preventive aspects of care along with quality measures to help its members measure healthcare processes and outcomes. · Journals that feature the latest research, review, practice guidelines and more on liver disease. These include Hepatology, the premier publication in the field of liver disease; Clinical Liver Disease, a free access multimedia review journal; and Hepatology Communications, a peer-reviewed, online, and open access journal. · Clinical resources for hepatologists and other clinicians. · Courses for clinicians and other healthcare professionals. · Tools to help professionals communicate effectively with patients. · The Cirrhosis Quality Collaborative, a multi-site learning health network that combines quality improvement and research to improve the care and treatment of patients with cirrhosis.